CHAPEL HILL, N.C., Sept. 29, 2017 /PRNewswire/ -- Pharmaceutical companies are turning to their medical affairs functionto enhance interactions with critical payer groups such as Accountable Care Organizations and Integrated Delivery Networks.
As the function that houses the roles dealing with health outcomes, medical affairs is positioned to deliver the value
To address these issues, Best Practices, LLC undertook benchmarking research to identify leading medical affairs strategies for payer and ACO/IDN engagement success, capturing critical metrics and insights on payer segmenting and targeting, data presentation and field resource deployment. The study also examines staff training, internal coordination, success factors and top challenges.
The report, "Medical Affairs Strategies to Deliver Value to Payers," identifies leading medical affairs strategies for payer and ACO/IDN engagement success.
Topics addressed in this report include:
This study engaged 18 leaders with direct experience working in medical and scientific affairs. Participants represent 18 leading pharmaceutical and medical device companies.
To learn more about this report, download a complimentary report excerpt at http://www.best-in-class.com/rr1466.htm.
For related research, visit the Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.
View original content:http://www.prnewswire.com/news-releases/new-pharmaceutical-industry-study-highlights-the-role-of-medical-affairs-in-payer-interactions-300527065.html
SOURCE Best Practices, LLC
Subscribe to our Free Newsletters!
Hay fever is caused by allergy to pollen and is characterized by runny or blocked nose, sneezing, ...
Therapeutic drug monitoring is measuring drug concentrations at specific intervals in a patient's ...
Sweet's syndrome or acute febrile neutrophilic dermatosis is a skin disorder with no specific ...View All